In our study, ARHGAP30 overexpression led to significant decreases in the protein expression of β-catenin, Bcl-2, MMP2, and MMP9 in pancreatic cancer cells and significant increases in Bax and cleaved caspase-3. This evidence concerns the gene ARHGAP30 and familial pancreatic carcinoma.